X

pharmaceuticals

Infographic: Highlights of Intuitive Surgical’s Q1 2022 earnings

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in…

Abbott Laboratories (ABT) Q1 2022 Infographic: Key financials and quarterly highlights

Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for…

Johnson & Johnson (JNJ) reports Q1 2022 earnings

Johnson & Johnson (NYSE: JNJ) reported first-quarter 2022 financial results before the regular market hours on Tuesday. The pharmaceutical giant…

AngioDynamics (ANGO) Q3 earnings beat estimates as sales increase

AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported higher earnings for the third quarter of 2022 when the medical device maker's…

Infographic: Highlights of Cronos’ (CRON) Q4 2021 earnings report

Cronos Group Inc. (NASDAQ: CRON) has reported a wider net loss for the fourth quarter of 2021, despite a double-digit…

Infographic: How Tilray (TLRY) performed in Q3 2022

Tilray (NASDAQ: TLRY) reported third-quarter 2022 financial results before the regular market hours on Wednesday. Total net revenue increased 23%…

Trxade will stay focused on traditional technology platform for margin growth: CEO Suren Ajjarapu

Can you briefly talk about your business model and the value you add to the market? Trxade (NASDAQ: MEDS) is…

Why Intuitive Surgical (ISRG) is a must-own stock after the recent dip

The pandemic had a mixed impact on the healthcare sector. The high demand for COIVD care services sent medical facilities…

HEXO Earnings: Highlights of Hexo’s Q2 2022 financial results

Cannabis producer HEXO Corp. (NASDAQ: HEXO) has reported a wider net loss for the second quarter of 2022. However, the…

Cipher Pharmaceuticals Inc. (CPH) Q4 2021 Earnings Call Transcript

Cipher Pharmaceuticals, Inc. ( TSX: CPH) Q4 2021 earnings call dated Mar. 18, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive…

Should you invest in Walgreens Boots Alliance ahead of earnings?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been busy enhancing its capabilities in healthcare delivery lately, through various initiatives including…

ANI Pharmaceuticals, Inc. (ANIP) Q4 2021 Earnings Call Transcript

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) Q4 2021 earnings call dated Mar. 15, 2022 Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President…

AN2 Therapeutics takes IPO route to advance pipeline. Here’s all you need to know

After starting the year on a high note, the IPO market is currently going through a slow phase mainly due…

Meihua’s IPO might set the stage for revival of Chinese listings in the US

Meihua International Medical Technologies is the latest healthcare company to seek Wall Street listing, even as the IPO market picks…

Infographic: Everything you need to know about Aurora Cannabis’ (ACB) Q2 earnings

Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a narrower net loss for the second quarter of 2022. The company's…

Infographic: Highlights of Canopy Growth’s (CGC) Q3 2022 earnings

Cannabis producer Canopy Growth Corporation (NASDAQ: CGC) reported a narrower net loss for the third quarter of 2022, despite an…

PFE Earnings: All you need to know about Pfizer’s Q4 2021 earnings results

Pfizer Inc. (NYSE: PFE) reported fourth quarter 2021 earnings results today. Revenues doubled year-over-year to $23.8 billion. Excluding contributions from…

Ocean Biomedical slashes IPO size. Should you invest in the stock?

The biomedical industry grew at an accelerated pace in 2021 even as healthcare systems went into overdrive amidst the COVID-induced…

Bristol Myers Squibb (BMY) Q4 Earnings: Key financials and quarterly highlights

Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2021 earnings results today. Total revenues increased 8% year-over-year to $12 billion,…

Infographic: A snapshot of Merck’s Q4 2021 earnings

Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than expected earnings and revenues for the fourth quarter. The…

Eli Lilly and Company (LLY) Earnings: 4Q21 Key Numbers

Eli Lilly and Company (NYSE: LLY) reported revenue of $7.9 billion for the fourth quarter of 2021, up 8% year-over-year.…